- Trials with a EudraCT protocol (27)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
27 result(s) found for: Th17 Cell.
Displaying page 1 of 2.
EudraCT Number: 2011-000924-14 | Sponsor Protocol Number: S52549 | Start Date*: 2011-05-23 |
Sponsor Name:KU Leuven LRD | ||
Full Title: Development and validation of a sputum biomarker mRNA panel for the diagnostic work-up of asthma | ||
Medical condition: asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001515-20 | Sponsor Protocol Number: 12971/16 | Start Date*: 2016-10-20 | |||||||||||
Sponsor Name:UNIVERSITÀ CATTOLICA DEL SACRO CUORE- POLICLINICO A. GEMELLI | |||||||||||||
Full Title: EFFECT OF TERIFLUNOMIDE ON T CELL SUBPOPULATIONS IN PERIPHERAL BLOOD FROM RRMS PATIENTS | |||||||||||||
Medical condition: RELAPSING-REMITTING MULTIPLE SCLEROSIS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004799-50 | Sponsor Protocol Number: PNEUMOREG | Start Date*: 2015-02-13 |
Sponsor Name:Federico Martinon Torres | ||
Full Title: Evaluation of the immunoregulatory role of pneumococcal conjugate vaccination in pediatric patients with allergic asthma or type 1 diabetes mellitus versus pediatric population control. | ||
Medical condition: Allergic asthma and type 1 diabetes mellitus in pediatric subjects. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002595-41 | Sponsor Protocol Number: AA1820 | Start Date*: 2018-09-05 | ||||||||||||||||
Sponsor Name:Herlev and Gentofte Hospital | ||||||||||||||||||
Full Title: CHECKPOINT INHIBITOR INDUCED COLITIS AND ARTHRITIS – IMMUNOMODULATION WITH IL-6 BLOCKADE AND EXPLORATION OF DISEASE MECHANISMS | ||||||||||||||||||
Medical condition: Immune therapy related adverse events (arthritis and colitis) in patients with solid tumors | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-003327-15 | Sponsor Protocol Number: TIDAM | Start Date*: 2022-02-21 |
Sponsor Name:Erasmus MC | ||
Full Title: An open-label, 8-week, proof of concept trial on thymosin-α1 (thymalfasin) in the treatment of primary antibody deficiency (PAD) associated mood disorders (TIDAM18). | ||
Medical condition: Primary immunodeficiency | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000585-41 | Sponsor Protocol Number: OG-061-01 | Start Date*: 2020-11-06 | ||||||||||||||||
Sponsor Name:T-Balance Therapeutics GmbH | ||||||||||||||||||
Full Title: Effects of tregalizumab on allergen-induced airway responses and airway inflammation in asthmatic patients | ||||||||||||||||||
Medical condition: mild controlled allergic asthma and house-dust mite (HDM) allergy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003466-39 | Sponsor Protocol Number: Protocol_MAMA_studie_22/05/2018 | Start Date*: Information not available in EudraCT |
Sponsor Name:University of Antwerp | ||
Full Title: Pertussis immunization during pregnancy: assessment of the role of maternal antibodies on immune responses in term and preterm infants (the MAMA study) | ||
Medical condition: The effect of pertussis vaccination during pregnancy on the immune response after infant and childhood vaccinations in term and preterm infants. | ||
Disease: | ||
Population Age: In utero, Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004419-35 | Sponsor Protocol Number: GN13RH410 | Start Date*: 2015-03-18 | |||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde [...] | |||||||||||||
Full Title: Inhibition of Co-Stimulation in Rheumatoid Arthritis | |||||||||||||
Medical condition: Rheumatoid Arthritis: patients who are dual ACPA and HLA-DR4 positive | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003191-14 | Sponsor Protocol Number: 21CH135 | Start Date*: 2021-08-16 | |||||||||||
Sponsor Name:CHU SAINT-ETIENNE | |||||||||||||
Full Title: Cohort assessing the immunogenicity and the safety of the COVID-19 Vaccine Janssen in healthy volunteers based on 3 age groups: 65 years or older - 55 to 65 years - 18 to 45 years - Covicompare-Jan... | |||||||||||||
Medical condition: volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001789-13 | Sponsor Protocol Number: 2016/02 | Start Date*: 2020-01-13 | ||||||||||||||||
Sponsor Name:Clinical Trials and Research Governance (CTRG), University of Oxford | ||||||||||||||||||
Full Title: A randomised, open label study, exploring the differences in immunogenicity and reactogenicity of infants after immunisation with either an acellular (aP) or whole cell pertussis (wP) vaccine | ||||||||||||||||||
Medical condition: This study is going to focus on the immunisations against pertussis disease in previous healthy children, but the disease itself is not going to be study. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002569-20 | Sponsor Protocol Number: BIELEFELD-Janssen-PHRCN-2017 | Start Date*: 2018-11-06 | |||||||||||
Sponsor Name:CHU Dijon Bourgogne | |||||||||||||
Full Title: A multicenter phase 2 single-arm proof-of-concept trial assessing the efficacy and safety of ustekinumab in association with prednisone, for the treatment of non-infectious severe uveitis (NISU) | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001696-36 | Sponsor Protocol Number: IL2REG | Start Date*: 2019-10-09 | |||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | |||||||||||||
Full Title: Study of efficacy of low-dose recombinant human interleukin-2 in immunological changes associated with depression (IL2REG) | |||||||||||||
Medical condition: Depressive episode in course of mood disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000445-12 | Sponsor Protocol Number: IPAR0001 | Start Date*: 2012-07-17 | |||||||||||
Sponsor Name:Department off Infectious Diseases, Aarhus University Hospital Skejby, Denmark | |||||||||||||
Full Title: Immune Response to Bivalent or Quadrivalent Human Papilloma Virus vaccination in Patients with Chronic Renal Failure | |||||||||||||
Medical condition: Cervical cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012424-87 | Sponsor Protocol Number: 2104091 | Start Date*: 2009-11-26 | |||||||||||||||||||||
Sponsor Name:Imperial College London South Kensington London | |||||||||||||||||||||||
Full Title: T cells and TNF: The impct of TNF blockade on effector T cell populations in rheumatoid arthritis and other conditions treated with anti-TNF-alpha agents. | |||||||||||||||||||||||
Medical condition: Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-005493-11 | Sponsor Protocol Number: CHPAU2014/01 | Start Date*: 2015-08-31 |
Sponsor Name:Centre Hospitalier de Pau | ||
Full Title: Intrathecal Rituximab in Progressive Multiple Sclerosis | ||
Medical condition: Patients included in our study suffer from a progressive form of Multiple sclerosis and will be treated by intravenous and intrathecal rituximab, with intravenous methylprednisolone. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-000709-10 | Sponsor Protocol Number: UKM12_0026 | Start Date*: 2014-12-19 | |||||||||||
Sponsor Name:Universitätsklinikum Münster | |||||||||||||
Full Title: Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential | |||||||||||||
Medical condition: relapsing-remitting multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005804-27 | Sponsor Protocol Number: 15-200 | Start Date*: 2016-06-04 | |||||||||||
Sponsor Name:CHU CAEN | |||||||||||||
Full Title: Essai randomisé, contrôlé, en double aveugle, de l'anakinra contre placebo, en adjonction à la corticothérapie dans l'artérite à cellules géantes. | |||||||||||||
Medical condition: Patients atteints d’artérite à cellules géantes (ou maladie de Horton) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003202-16 | Sponsor Protocol Number: PB/0046 | Start Date*: 2015-10-20 |
Sponsor Name:Academic Medical Centre | ||
Full Title: A randomized, double-blind, placebo-controlled study to compare the safety and immune effects of multiple doses of vitamin D3 in patients with allergic rhinitis/rhino-conjunctivitis caused by birc... | ||
Medical condition: subcutaneous immunotherapy in allergic rhinits (AR) patients with allergies to birchpollen | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001339-33 | Sponsor Protocol Number: SCITVITD3 | Start Date*: 2018-07-05 |
Sponsor Name:Academisch medisch centrum Amsterdam | ||
Full Title: A randomized, double-blind, placebo-controlled, study to determine the added value of vitamin D3 to treatment with subcutaneous immunotherapy in patients with moderate to severe allergic rhinitis/ ... | ||
Medical condition: subcutaneous immunotherapy in allergic rhinitis (AR) patients with allergies to birchpollen | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-000875-37 | Sponsor Protocol Number: VanC-IT | Start Date*: 2022-11-03 | |||||||||||
Sponsor Name:UNIVERSITÀ DEGLI STUDI MILANO BICOCCA | |||||||||||||
Full Title: A Prospective, Randomized, Placebo-controlled Clinical Trial of oral vancomycin in adults and young adults (15-17 years old) affected by Primary Sclerosing Cholangitis with or without Inflammatory ... | |||||||||||||
Medical condition: Primary Sclerosing Cholangitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.